Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Downsides to the nitrate–nitrite–nitric oxide pathway in physiology and therapeutics?

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Lundberg, J. O., Weitzberg, E. & Gladwin, M. T. The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics. Nature Rev. Drug Discov. 7, 156–167 (2008).

    Article  CAS  Google Scholar 

  2. Millar, T. M. et al. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett. 427, 225–228 (1998).

    Article  CAS  Google Scholar 

  3. Cosby, K. et al. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nature Med. 9, 1498–1505 (2003).

    Article  CAS  Google Scholar 

  4. Panesar, N. S. Role of chloride and inhibitory action of inorganic nitrate on gonadotropin-stimulated steroidogenesis in mouse Leydig tumor cells. Metabolism 48, 693–700 (1999).

    Article  CAS  Google Scholar 

  5. Panesar, N. S. & Chan, K. W. Decreased steroid hormone synthesis from inorganic nitrite and nitrate. Studies in vitro and in vivo. Toxicol. Appl. Pharmacol. 169, 222–230 (2000).

    Article  CAS  Google Scholar 

  6. Hodge, L. Environmental Pollution (Holt, Rinehart and Winston, New York, 1973).

    Google Scholar 

  7. MacArthur, P. H., Shiva, S. & Gladwin, M. T. Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence. J. Chromatogr. B 851, 93–105 (2007).

    Article  CAS  Google Scholar 

  8. Pelley, J. Nitrate eyed as endocrine disrupter. Environ. Sci. Tech. 37, 162A (2003).

    Article  Google Scholar 

  9. White, P. C., New, M. I. & Dupont B. Congenital adrenal hyperplasia. N. Engl. J. Med. 316, 1519–1524 (1987).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Panesar, N. Downsides to the nitrate–nitrite–nitric oxide pathway in physiology and therapeutics?. Nat Rev Drug Discov 7, 710 (2008). https://doi.org/10.1038/nrd2466-c1

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nrd2466-c1

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing